exRNAdisease

Entry Detail

---



General Information

Database ID: exR0358527 RNA Name: hsa-miR-7-5p RNA Type: miRNA Chromosome: chr19 Starnd: + Coordinate: Start Site(bp): 4770700 End Site(bp): 4770723 External Links: hsa-miR-7-5p

Disease Information

Disease Name: Breast Cancer Disease Category: Cancers MeSH ID: D001943 Type: Neoplasms/Breast Neoplasms Alias: Breast Neoplasms//Breast Neoplasm//Neoplasm, Breast//Breast Tumors//Breast Tumor//Tumor, Breast//Tumors, Breast//Neoplasms, Breast//Breast Cancer//Cancer, Breast//Mammary Cancer//Cancer, Mammary//Cancers, Mammary//Mammary Cancers//Malignant Neoplasm of Breast//Breast Malignant Neoplasm//Breast Malignant Neoplasms//Malignant Tumor of Breast//Breast Malignant Tumor//Breast Malignant Tumors//Cancer of Breast//Cancer of the Breast//Mammary Carcinoma, Human//Carcinoma, Human Mammary//Carcinomas, Human Mammary//Human Mammary Carcinomas//Mammary Carcinomas, Human//Human Mammary Carcinoma//Mammary Neoplasms, Human//Human Mammary Neoplasm//Human Mammary Neoplasms//Neoplasm, Human Mammary//Neoplasms, Human Mammary//Mammary Neoplasm, Human//Breast Carcinoma//Breast Carcinomas//Carcinoma, Breast//Carcinomas, Breast

Expression Detail

GEO ID: GSE98181 Description: Circulating miRNA profiles from serum of women at high-risk for breast cancer Experimental Design: Cancer vs Control Case Disease Type: Breast Cancer Case Disease SubType: NA Case Sample: Breast Cancer Control Sample: Healthy Number of Case: 24 Number of Control: 24 Number of Samples: 48

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand RCC2 chr1 17406760 17439677 - GNA12 chr7 2728105 2844308 - RAB29 chr1 205767986 205775482 - TSPAN14 chr10 80454166 80533124 + INTS2 chr17 61865367 61928016 - ACVR1B chr12 51951699 51997078 + RPS6KB1 chr17 59893046 59950574 + SCD chr10 100347233 100364826 + INSR chr19 7112255 7294414 - SLC25A44 chr1 156193932 156212796 + KMT2D chr12 49018975 49059774 - ORAI1 chr12 121626550 121642677 + ATXN1 chr6 16299112 16761491 - NAPA chr19 47487637 47515091 - HP1BP3 chr1 20740266 20787323 - SETD7 chr4 139495941 139606699 - PLXNA1 chr3 126988594 127037392 + KLHL18 chr3 47282917 47346816 + IRS2 chr13 109752695 109786583 - CBL chr11 119206298 119313926 + VPS4A chr16 69311350 69326939 + DNAJC9 chr10 73183362 73247255 - PATL1 chr11 59636716 59669037 - MEPCE chr7 100428790 100434118 + FYCO1 chr3 45917899 45995824 - JAM3 chr11 134069071 134152001 + HMGA2 chr12 65824131 65966295 + TM4SF1 chr3 149369022 149377692 - DHCR24 chr1 54849627 54887195 - RUSC1 chr1 155320894 155331114 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000712 chr16 68208276 68225678 + hsa_circ_0001168 chr20 47691321 47707559 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC016876.2 chr17 7581964 7584086 - AC105339.2 chr15 82752884 82757208 + AL096870.2 chr14 24209646 24215987 - AL590617.2 chr6 138692548 138697288 + MIR497HG chr17 7015818 7019659 - OIP5-AS1 chr15 41283990 41309737 + SNHG1 chr11 62851984 62855953 - TBC1D3P1-DHX40P1 chr17 59962363 60018975 - U91328.1 chr6 25992641 26001775 + XIST chrX 73820649 73852723 - ZFAS1 chr20 49278178 49299600 + Display:

Experiment Detail

GEO ID: GSE98181 Sample Source: Blood Source Fraction: Serum Platform: GPL21572 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2546 Sample treatment protocol: Serum is obtained from coagulated whole blood samples by centrifugation at 3000 rpm for 10 minutes. RNA Extract protocol: RNA was isolated from a 200ul serum aliquot using the miRNeasy Serum Plasma kit with ce-miR-39 spike-in (QIAGEN), QIAcube (QIAGEN) automation, and eluted with 14uL of nuclease-free water. RNA library preparation protocol: Exactly 8ul of RNA was tagged with a Poly-A tail, using an ATP driven reaction from the Affymetrix® FlashTag™ Biotin HSR RNA Labeling Kit.

Reference

PMID: 29348816 Title: Development of a predictive miRNA signature for breast cancer risk among high-risk women. Author: Farina NH, Ramsey JE, Cuke ME, Ahern TP, Shirley DJ, Stein JL, Stein GS, Lian JB, Wood ME Journal: Oncotarget. 2017 Nov 28;8(68):112170-112183. Description: We evaluated the ability of C-miRNAs to identify women most likely to develop breast cancer by profiling miRNA from serum obtained long before diagnosis.